Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Supriya Lifescience Limited
SUPRIYACurrent price
644.4 INR
+35.5 INR (+5.83%)
Last closed
608.9 INR
Company
www.supriyalifescience.com
ISIN
INE07RO01027
Sector
Healthcare
Industry
Biotechnology
Exchange
National Stock Exchange of India
Capitalization
52 200 176 899 INR
Yield for 12 month
+158.33 %
1Y
3Y
5Y
10Y
15Y
SUPRIYA
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti"hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, the company is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessasion, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic, stem cell transplantation, and anti-migraine. The company was founded in 1987 and is headquartered in Mumbai, India. Address: 207/208 Udyog Bhavan, Mumbai, India, 400063
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
48 126.95 INRP/E ratio
33.2291Dividend Yield
0.13 %Current Year
+5 706 233 743 INR
Last Year
+4 611 427 629 INR
Current Quarter
+1 661 757 832 INR
Last Quarter
+1 606 973 570 INR
Current Year
+2 652 978 024 INR
Last Year
+2 802 504 414 INR
Current Quarter
+1 201 803 644 INR
Last Quarter
+873 277 748 INR
Key Figures SUPRIYA
1 year
3 years
5 years
10 years
EBITDA
5 275 742 369 INR
Operating Margin TTM
PE Ratio
33.2291
Return On Assets TTM
34.42 %
PEG Ratio
–
Return On Equity TTM
18.99 %
Wall Street Target Price
48 126.95 INR
Revenue TTM
6 252 596 508 INR
Book Value
112.13 INR
Revenue Per Share TTM
Dividend Share
0.8 INR
Quarterly Revenue Growth YOY
18.6 %
Dividend Yield
0.13 %
Gross Profit TTM
2 649 696 548 INR
Earnings per share
19.52 INR
Diluted Eps TTM
19.52 INR
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
92.3 %
Profit Margin
25.2 %
Dividend Analytics SUPRIYA
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
4 %Dividend History SUPRIYA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.8
Ex Dividend Date
20.09.2024
Forward Annual Dividend Yield
0.12 %
Last Split Factor
–
Payout Ratio
9.65 %
Last Split Date
–
Dividend Date
–
Stock Valuation SUPRIYA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
33.2291
Forward PE
–
Enterprise Value Revenue
8.3827
Price Sales TTM
8.3962
Enterprise Value EBITDA
21.755
Price Book MRQ
5.7598
Financials SUPRIYA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SUPRIYA
For 52 weeks
239.59 INR
690.16 INR
50 Day MA
591.32 INR
Shares Short Prior Month
–
200 Day MA
440.92 INR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart